We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Respiratory Medicine

Journal Scan / Research · August 07, 2019

Pathogen Acquisition in Patients With Cystic Fibrosis Receiving Ivacaftor or Lumacaftor/Ivacaftor

Pediatric Pulmonology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Pediatric Pulmonology
Pathogen Acquisition in Patients With Cystic Fibrosis Receiving Ivacaftor or Lumacaftor/Ivacaftor
Pediatr. Pulmonol. 2019 Aug 01;54(8)1200-1208, SB Singh, AJ McLearn-Montz, F Milavetz, LK Gates, C Fox, LT Murry, A Sabus, HS Porterfield, AJ Fischer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading